⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GCTK News
GlucoTrack, Inc. Common Stock
Form 8-K
sec.gov
GCTK
Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
businesswire.com
GCTK
Form 8-K/A
sec.gov
GCTK
Form 8-K
sec.gov
GCTK
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing
globenewswire.com
GCTK
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
globenewswire.com
GCTK
UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
globenewswire.com
GCTK
Form 8-K
sec.gov
GCTK
Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
globenewswire.com
GCTK
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
globenewswire.com
GCTK